Genfleet Therapeutics (shanghai) Inc.
Clinical trials sponsored by Genfleet Therapeutics (shanghai) Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for KRAS G12D lung cancer: targeted drug combo enters trial Results expected Apr 2027 (estimated)
- New pill takes on tough pancreatic cancer in major trial Results expected Jun 2027 (estimated)
- New hope for hard-to-treat cancers: targeted combo therapy enters trials Results expected Jul 2027 (estimated)